4//SEC Filing
DARCY THOMAS E 4
Accession 0000899243-21-002094
CIK 0001419041other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:17 PM ET
Size
10.6 KB
Accession
0000899243-21-002094
Insider Transaction Report
Form 4
DARCY THOMAS E
DirectorExecutive Vice President
Transactions
- Exercise/Conversion
Common Stock
2021-01-13$9.59/sh+500$4,793→ 2,358 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-13−500→ 0 totalExercise: $9.59Exp: 2021-06-15→ Common Stock (500 underlying)
Holdings
- 24,637(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019. The option originally covered 7,500 shares pre 15-to-1 reverse stock split which became effective on June 15, 2020.
- [F2]The Form 4 filed October 4, 2019 incorrectly reported the Expiration Date as October 3, 2029. The correct Expiration Date is June 15, 2021.
Issuer
Forte Biosciences, Inc.
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001126910
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 7:17 PM ET
- Size
- 10.6 KB